← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Regulonix, Llc
New York, NY
$1,685,692
Total funding
5
Grants
Funding over time
peak $819.5K · FY2017–21$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$1,685,692 · 5
By mechanism
R41$1,685,692 · 5
Investigators at Regulonix, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Targeting the neuropilin-1 receptor (NRP-1)/VEGF-A axis for neuropathic pain$419,470
R41 · FY2021 · NS
Inhibition of CaVα-β interaction with orally available small organic molecules for chronic pain$400,000
R41 · FY2021 · CA
Discovery of T-type Calcium Channel Antagonists from Multicomponent Reactions and Their Application in Paclitaxel-induced Peripheral Neuropathy$341,527
R41 · FY2019 · NS
Regulators of NaV1.7 Channels: Novel Anti-Allodynic Drug Candidates$299,999
R41 · FY2017 · CA
Optimization of Betulinic Acid analogs for T-type calcium channel inhibition for non-addictive relief of chronic pain$224,696
R41 · FY2019 · DA